Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-04-15 Sale | 2024-04-17 4:36 pm | Crinetics Pharmaceuticals Inc. | CRNX | Pizzuti Dana Chief Med and Dev Officer | 14,375 | $44.47 | $639,256 | 205,078 (Direct) | View |
| 2024-03-20 Sale | 2024-03-22 4:52 pm | Crinetics Pharmaceuticals Inc. | CRNX | Pizzuti Dana Chief Med and Dev Officer | 15,089 | $44.06 | $664,763 | 421,120 (Direct) | View |
| 2024-01-03 Sale | 2024-01-04 4:45 pm | Crinetics Pharmaceuticals Inc. | CRNX | Pizzuti Dana Chief Med and Dev Officer | 14,375 | $35 | $503,125 | 211,953 (Direct) | View |
| 2023-12-21 Sale | 2023-12-22 6:45 pm | Crinetics Pharmaceuticals Inc. | CRNX | Pizzuti Dana Chief Med and Dev Officer | 9,583 | $34.57 | $331,284 | 226,328 (Direct) | View |
| 2023-04-05 Sale | 2023-04-05 7:12 pm | Crinetics Pharmaceuticals Inc. | CRNX | Pizzuti Dana Chief Development Officer | 8,212 | $16.15 | $132,624 | 4,500 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-04-15 Exercise | 2024-04-17 4:36 pm | N/A 2032-10-10 | Crinetics Pharmaceuticals Inc. | CRNX | Pizzuti Dana Chief Med and Dev Officer | 14,375 | $0 | 205,078 (Direct) | View |
| 2024-04-15 Exercise | 2024-04-17 4:36 pm | N/A N/A | Crinetics Pharmaceuticals Inc. | CRNX | Pizzuti Dana Chief Med and Dev Officer | 14,375 | $16.89 | 205,078 (Direct) | View |
| 2024-03-20 Exercise | 2024-03-22 4:52 pm | N/A 2032-10-10 | Crinetics Pharmaceuticals Inc. | CRNX | Pizzuti Dana Chief Med and Dev Officer | 14,375 | $0 | 421,120 (Direct) | View |
| 2024-03-20 Exercise | 2024-03-22 4:52 pm | N/A N/A | Crinetics Pharmaceuticals Inc. | CRNX | Pizzuti Dana Chief Med and Dev Officer | 14,375 | $16.89 | 421,120 (Direct) | View |
| 2024-03-18 Tax Withholding | 2024-03-20 6:36 pm | N/A N/A | Crinetics Pharmaceuticals Inc. | CRNX | Pizzuti Dana Chief Med and Dev Officer | 411 | $38.14 | 28,500 (Direct) | View |
| 2024-03-04 Option Award | 2024-03-06 8:00 pm | N/A 2034-03-03 | Crinetics Pharmaceuticals Inc. | CRNX | Pizzuti Dana Chief Med and Dev Officer | 110,000 | $0 | 115,911 (Direct) | View |
| 2024-01-03 Exercise | 2024-01-04 4:45 pm | N/A 2032-10-10 | Crinetics Pharmaceuticals Inc. | CRNX | Pizzuti Dana Chief Med and Dev Officer | 14,375 | $0 | 211,953 (Direct) | View |
| 2024-01-03 Exercise | 2024-01-04 4:45 pm | N/A N/A | Crinetics Pharmaceuticals Inc. | CRNX | Pizzuti Dana Chief Med and Dev Officer | 14,375 | $16.89 | 211,953 (Direct) | View |
| 2023-12-21 Exercise | 2023-12-22 6:45 pm | N/A 2032-10-10 | Crinetics Pharmaceuticals Inc. | CRNX | Pizzuti Dana Chief Med and Dev Officer | 9,583 | $0 | 226,328 (Direct) | View |
| 2023-12-21 Exercise | 2023-12-22 6:45 pm | N/A N/A | Crinetics Pharmaceuticals Inc. | CRNX | Pizzuti Dana Chief Med and Dev Officer | 9,583 | $16.89 | 226,328 (Direct) | View |
| 2023-04-03 Tax Withholding | 2023-04-05 7:12 pm | N/A N/A | Crinetics Pharmaceuticals Inc. | CRNX | Pizzuti Dana Chief Development Officer | 4,288 | $15.98 | 4,500 (Direct) | View |
| 2023-03-01 Option Award | 2023-03-03 4:44 pm | N/A 2033-02-28 | Crinetics Pharmaceuticals Inc. | CRNX | Pizzuti Dana Chief Development Officer | 25,500 | $0 | 38,000 (Direct) | View |
| 2022-10-10 Option Award | 2022-10-11 4:35 pm | N/A 2032-10-09 | Crinetics Pharmaceuticals Inc. | CRNX | Pizzuti Dana Chief Development Officer | 242,500 | $0 | 242,500 (Direct) | View |